Omeprazole/Tegaserod and Gastric Emptying

Published Online: Thursday, September 1, 2005

Proton pump inhibitors (PPIs) effectively suppress stomach acidity and are widely used in treating gastroesophageal reflux disease and related conditions. Omeprazole and other PPIs, however, can delay gastric emptying. In a study published in Alimentary Pharmacology & Therapeutics (July 2005), Gervais Tougas, MD, FRCPC, et al tested the hypothesis that treatment with tegaserod normalizes or prevents omeprazole-induced delayed gastric emptying. For the study, 40 healthy men were treated with omeprazole (20 mg bid) and either tegaserod (6 mg tid) or placebo for 14 days. Gastric emptying was assessed by scintigraphy before and after treatment.

Omeprazole monotherapy significantly delayed gastric emptying expressed by duration of lag phase (P < .007), time to gastric half-emptying (P < .003), and gastric retention of the meal at 60 minutes (P < .002) and 120 minutes (P < .04) after ingestion. Combination therapy with tegaserod and omeprazole safely and effectively prevented the development of delayed gastric emptying induced by omeprazole.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues